1-Chromonyl-5-Imidazolylpentadienone Demonstrates Anti-Cancer Action against TNBC and Exhibits Synergism with Paclitaxel

1-Chromonyl-5-Imidazolylpentadienone Demonstrates Anti-Cancer Action against TNBC and Exhibits Synergism with Paclitaxel

Curcumin has been well studied for its anti-oxidant, anti-inflammatory, and anti-cancer action. Its potential as a therapy is limited due to its low bioavailability and rapid metabolism. To overcome these challenges, investigators are developing curcumin analogs, nanoparticle formulations, and combi...

Full description

Bibliographic Details
Main Authors: Karan Modi, Scott Lawson, Guanglin Chen, Deepthi Tumuluri, Inga Rekhtman, Michael Kurtz, G. Cristina Brailoiu, Qiao-Hong Chen, Ashakumary Lakshmikuttyamma
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:International Journal of Molecular Sciences
Subjects:
curcumin
triple-negative breast cancer
paclitaxel
IL-6
Online Access:https://www.mdpi.com/1422-0067/21/16/5777

Internet

https://www.mdpi.com/1422-0067/21/16/5777

Similar Items